HHS Reissues PHS 2013-02 SBIR and STTR Omnibus Grant Solicitations Implementing Venture Capital Provision and SBA Company Registry Requirement of the SBIR/STTR Reauthorization Act of 2011

Posted on May 31, 2013

The PHS 2013-2 Omnibus Solicitation of the NIH, CDC, FDA, and ACF for SBIR/STTR Grant Applications and SF 424 (R&R) Application Guide for SBIR/STTR Grant Applications are now reissued. The reissued solicitation consists of: (1) re-issued parent funding opportunity announcement (FOA) for SBIR, (2) re-issued parent FOA for STTR, and (3) narrative descriptions of the programs and research topics (in PDF - 1 MB and MS Word - 1 MB formats). The remaining due dates for CY 2013 are August 5 and December 5, 2013.  AIDS and AIDS-related applications are due September 7, 2013 and January 7, 2014.

The original SBIR and STTR Omnibus solicitations, PA-13-088 (SBIR) and PA-13-089 (STTR) are now expired.  Applications can no longer be submitted to these FOAs, applicants will receive an error in their submission if these expired FOAs are used.  Applicants must download and use the reissued FOAs, PA-13-234 (SBIR) and PA-13-235 (STTR), for ALL SBIR and STTR Omnibus submissions for the remaining due dates listed above.  This includes resubmissions ('-A1s'). 

This re-issuance implements two additional provisions of the Reauthorization Act: 1) majority venture-capital owned companies may now apply to the NIH SBIR program and 2) all small business concerns must register in the SBA Company Registry.

See NIH Guide Notice NOT-OD-13-071 for details.



 


 

May 31, 2013
May 31, 2013